Affiniclonal

Our main goal is to develop a new biotechnology platform for Monoclonal Antibody (mAb) production introducing a cost effective application for industrial processes.

Nowadays, the main industry efforts in mAb production is directed to improve the performance in therapeutic application. Therefore its cost restricts its application in downstream processing in biotech industry.

With our platform development, we aim to reduce the mAb production cost applying a Unique System for affinity chromatographic application. Industrial production costs and duration will be cut down introducing this step in downstream process. This approach will allow wide range application in biotech industry.

Our first steps in this direction are the Affinity Resin and  the Diagnostic Kit  for veterinary application.